Acquisition Pending

Rallybio acquisition of Avenzo Therapeutics

Announced 1 Jun 2026

Advisers

Avenzo Therapeutics

Target

Financial adviser
Legal adviser

Rallybio

Acquirer

Financial adviser
Legal adviser
Target
Avenzo Therapeutics
Acquirer
Rallybio
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.